Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 10, 2015 - Issue
Submit an article Journal homepage
58
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort

Yu-Feng Wei1 Department of Internal Medicine, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan
,
Ping-Hung Kuo2 Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanCorrespondence[email protected]
,
Ying-Huang Tsai3 Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan
,
Chi-Wei Tao4 Department of Internal Medicine, Cheng-Hsin General Hospital, Taipei, Taiwan
,
Shih-Lung Cheng5 Division of Thoracic Medicine, Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan;13 Department of Chemical Engineering and Materials Science, Yuan-Ze University, Taoyuan, Taiwan
,
Chao-Hsien Lee6 Division of Pulmonary and Critical Care Medicine, Mackay Memorial Hospital, Taipei, Taiwan
,
Yao-Kuang Wu7 Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Tzu Chi Hospital, Taipei, Taiwan
,
Ning-Hung Chen8 Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan
,
Wu-Huei Hsu9 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University and China Medical University Hospital, Taichung, Taiwan
,
Jeng-Yuan Hsu10 Division of Chest Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
,
Ming-Shian Lin11 Division of Pulmonary and Critical Care Medicine, Chia-Yi Christian Hospital, Chiayi, Taiwan
&
Chin-Chou Wang12 Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
 show all
Pages 1951-1956 | Published online: 14 Sep 2015

References

  • HsiaoAJChenLHLuTHTen leading causes of death in Taiwan: a comparison of two grouping listsJ Formos Med Assoc Epub1202014
  • WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
  • VogelmeierCHedererBGlaabTTiotropium versus salmeterol for the prevention of exacerbations of COPDN Engl J Med2011364121093110321428765
  • CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • de Miguel-DiezJCarrasco-GarridoPRejas-GutierrezJInappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health statusLung2011189319920621499887
  • WhitePThorntonHPinnockHGeorgopoulouSBoothHPOver-treatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational studyPLoS One2013810e7522124194824
  • KoblizekVPecenLZatloukalJReal-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatmentPLoS One2014911e11107825380287
  • ThomasMRadwanAStonhamCMarshallSCOPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary careCOPD201411330030924152210
  • VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • NanniniLJLassersonTJPoolePCombined corticosteroid and long-acting β2-agonist in one inhaler versus long-acting β2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20129CD00682922972099
  • FesticEScanlonPDIncident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?Am J Respir Crit Care Med2015191214114825409118
  • ChoudhuryABDawsonCMKilvingtonHEWithdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trialRespir Res200789318162137
  • van der ValkPMonninkhofEvan der PalenJZielhuisGvan HerwaardenCEffect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE studyAm J Respir Crit Care Med2002166101358136312406823
  • WoutersEFPostmaDSFokkensBWithdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trialThorax200560648048715923248
  • RossiAGuerrieroMCorradoAWithdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)Respir Res2014157725005873
  • MagnussenHDisseBRodriguez-RoisinRWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
  • KunzLIPostmaDSKloosterKRelapse in FEV1-decline after steroid withdrawal in chronic obstructive pulmonary diseaseChest Epub422015
  • PapaiwannouAZarogoulidisPPorpodisKAsthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature reviewJ Thorac Dis20146Suppl 1S146S15124672688
  • JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.